Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5494622 | 0.86 | ALDH1A1 (0.36) | MEN1KMT2AALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL29438029 | 0.85 | ALDH1A1 (0.39) | ALDH1A1CYP1A2CYP2C19CYP3A4CYP2C9 | |
| SCHEMBL6315068 | 0.85 | OPRM1 (0.40) | TRPM8ALDH1A1CYP1A2CYP2C19CYP2C9 | |
| SCHEMBL6401268 | 0.85 | OPRM1 (0.40) | TRPM8ALDH1A1CYP1A2CYP2C19CYP2C9 | |
| SCHEMBL5914841 | 0.85 | GRM6 (0.35) | MEN1KMT2AALDH1A1GAALMNA | |
| SCHEMBL5914861 | 0.84 | THRB (0.34) | ALDH1A1SMN1; SMN2ALOX5NPC1RAB9A | |
| SCHEMBL3958398 | 0.84 | THRB (0.34) | ALDH1A1SMN1; SMN2ALOX5NPC1RAB9A | |
| SCHEMBL6315318 | 0.84 | THRB (0.34) | ALDH1A1SMN1; SMN2ALOX5NPC1RAB9A | |
| SCHEMBL14481379 | 0.82 | MEN1 (0.38) | MEN1KMT2AHTTTRPM8ALDH1A1 | |
| SCHEMBL6988447 | 0.75 | ALOX5 (0.33) | MEN1KMT2ATRPM8ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060270857-A1 | Production methods of thiazoline compounds and optically active alpha-alkylcysteine | AJINOMOTO CO., INC. (JP) | 2006-11-30 | — | — | US | disclosed |
| EP-1721902-A1 | Production methods of thiazoline compounds and optically active alpha-alkylcysteine | Ajinomoto Co., Inc. (JP) | 2006-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060270857-A1 | Production methods of thiazoline compounds and optically active alpha-alkylcysteine | CTH, NAT1, AADAC | MEN1 3548/4885KMT2A 3029/4885HTT 1566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.